<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T03:51:12Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:7303006" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:7303006</identifier>
        <datestamp>2020-06-23</datestamp>
        <setSpec>npgopen</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Mol Psychiatry</journal-id>
              <journal-id journal-id-type="iso-abbrev">Mol. Psychiatry</journal-id>
              <journal-title-group>
                <journal-title>Molecular Psychiatry</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">1359-4184</issn>
              <issn pub-type="epub">1476-5578</issn>
              <publisher>
                <publisher-name>Nature Publishing Group UK</publisher-name>
                <publisher-loc>London</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC7303006</article-id>
              <article-id pub-id-type="pmcid">PMC7303006</article-id>
              <article-id pub-id-type="pmc-uid">7303006</article-id>
              <article-id pub-id-type="pmid">31695168</article-id>
              <article-id pub-id-type="publisher-id">574</article-id>
              <article-id pub-id-type="doi">10.1038/s41380-019-0574-2</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Intrinsic connectomes are a predictive biomarker of remission in major depressive disorder</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Korgaonkar</surname>
                    <given-names>Mayuresh S.</given-names>
                  </name>
                  <address>
                    <email>m.korgaonkar@sydney.edu.au</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Goldstein-Piekarski</surname>
                    <given-names>Andrea N.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Fornito</surname>
                    <given-names>Alexander</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff5">5</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9987-7360</contrib-id>
                  <name>
                    <surname>Williams</surname>
                    <given-names>Leanne M.</given-names>
                  </name>
                  <address>
                    <email>leawilliams@stanford.edu</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                </contrib>
                <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 834X</institution-id><institution-id institution-id-type="GRID">grid.1013.3</institution-id><institution>The Brain Dynamics Centre, Westmead Institute for Medical Research, </institution><institution>The University of Sydney, </institution></institution-wrap>Sydney, Australia </aff>
                <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 834X</institution-id><institution-id institution-id-type="GRID">grid.1013.3</institution-id><institution>Discipline of Psychiatry, Western Clinical School, </institution><institution>The University of Sydney, </institution></institution-wrap>Sydney, Australia </aff>
                <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000000419368956</institution-id><institution-id institution-id-type="GRID">grid.168010.e</institution-id><institution>Department of Psychiatry and Behavioral Sciences, </institution><institution>Stanford University, </institution></institution-wrap>Stanford, California USA </aff>
                <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0419 2556</institution-id><institution-id institution-id-type="GRID">grid.280747.e</institution-id><institution>Sierra-Pacific Mental Illness Research, Education, and Clinical Center (MIRECC) VA Palo Alto Health Care System, </institution></institution-wrap>Palo Alto, CA USA </aff>
                <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 7857</institution-id><institution-id institution-id-type="GRID">grid.1002.3</institution-id><institution>Brain and Mental Health Research Hub, Turner Institute for Brain and Mental Health &amp; Monash Biomedical Imaging, </institution><institution>Monash University, </institution></institution-wrap>Clayton, Victoria Australia </aff>
              </contrib-group>
              <pub-date pub-type="epub">
                <day>6</day>
                <month>11</month>
                <year>2019</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>6</day>
                <month>11</month>
                <year>2019</year>
              </pub-date>
              <pub-date pub-type="ppub">
                <year>2020</year>
              </pub-date>
              <volume>25</volume>
              <issue>7</issue>
              <fpage>1537</fpage>
              <lpage>1549</lpage>
              <history>
                <date date-type="received">
                  <day>15</day>
                  <month>4</month>
                  <year>2019</year>
                </date>
                <date date-type="rev-recd">
                  <day>7</day>
                  <month>10</month>
                  <year>2019</year>
                </date>
                <date date-type="accepted">
                  <day>23</day>
                  <month>10</month>
                  <year>2019</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© The Author(s) 2019</copyright-statement>
                <license license-type="OpenAccess">
                  <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
                </license>
              </permissions>
              <abstract id="Abs1">
                <p id="Par1">Although major depressive disorder (MDD) is associated with altered functional coupling between disparate neural networks, the degree to which such measures are ameliorated by antidepressant treatment is unclear. It is also unclear whether functional connectivity can be used as a predictive biomarker of treatment response. Here, we used whole-brain functional connectivity analysis to identify neural signatures of remission following antidepressant treatment, and to identify connectomic predictors of treatment response. 163 MDD and 62 healthy individuals underwent functional MRI during pre-treatment baseline and 8-week follow-up sessions. Patients were randomized to escitalopram, sertraline or venlafaxine-XR antidepressants and assessed at follow-up for remission. Baseline measures of intrinsic functional connectivity between each pair of 333 regions were analyzed to identify pre-treatment connectomic features that distinguish remitters from non-remitters. We then interrogated these connectomic differences to determine if they changed post-treatment, distinguished patients from controls, and were modulated by medication type. Irrespective of medication type, remitters were distinguished from non-remitters by greater connectivity within the default mode network (DMN); specifically, between the DMN, fronto-parietal and somatomotor networks, the DMN and visual, limbic, auditory and ventral attention networks, and between the fronto-parietal and somatomotor networks with cingulo-opercular and dorsal attention networks. This baseline hypo-connectivity for non-remitters also distinguished them from controls and increased following treatment. In contrast, connectivity for remitters was higher than controls at baseline and also following remission, suggesting a trait-like connectomic characteristic. Increased functional connectivity within and between large-scale intrinsic brain networks may characterize acute recovery with antidepressants in depression.</p>
              </abstract>
              <kwd-group kwd-group-type="npg-subject">
                <title>Subject terms</title>
                <kwd>Prognostic markers</kwd>
                <kwd>Depression</kwd>
              </kwd-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution>Brain Resource Ltd, San Francisco &amp; Sydney</institution>
                  </funding-source>
                </award-group>
              </funding-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution>Brain Resource Ltd (iSPOT-D Clinical Trial NCT00693849)</institution>
                  </funding-source>
                </award-group>
              </funding-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>issue-copyright-statement</meta-name>
                  <meta-value>© Springer Nature Limited 2020</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec id="Sec1" sec-type="introduction">
              <title>Introduction</title>
              <p id="Par2">Antidepressant medications remain the first-line treatment for major depressive disorders (MDD) [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>], yet more than 50% of patients fail to achieve remission upon initial treatment [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. Failure to respond to first-line treatments not only lengthens recovery time, but also reduces response rates to subsequent medications, contributing to the enormous burden of disease to the patient, family, health systems and society [<xref ref-type="bibr" rid="CR5">5</xref>]. Understanding neurobiological mechanisms of antidepressant action is crucial to elucidating the characteristics of favorable treatment outcome. Intensive research using advanced neuroimaging techniques over the past few decades has shed light on the neurobiological substrates of depression [<xref ref-type="bibr" rid="CR6">6</xref>]. However, our understanding of the neural mechanisms through which some people recover on antidepressants and some people do not is still rudimentary.</p>
              <p id="Par3">The human brain is intrinsically organized into distinct, functionally coherent networks, whose synchrony underlies cognitive and emotional processes [<xref ref-type="bibr" rid="CR7">7</xref>]. MDD has been characterized by abnormal interactions within and between these intrinsic brain networks, particularly those that regulate awareness of internal states (i.e., the default mode network, DMN), external awareness (the dorsal attention network, DAN), those involved in top-down regulation of attention and emotion (fronto-parietal network, FPN; and cingulopercular network, CON); and those involved in processing of emotion (affective network, AN) and monitoring for salient events (ventral attention network, VAN). Specific patterns of aberrant communication between these networks are known to contribute to core cognitive and affective deficits in MDD [<xref ref-type="bibr" rid="CR8">8</xref>].</p>
              <p id="Par4">Increasing attention is being paid to understanding the effects that antidepressant medications exert on brain connectivity in MDD, as measured using either task-free or task-based fMRI (reviewed recently in refs. [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]). Treatment with antidepressants have consistently found to alter functional connectivity of the DMN [<xref ref-type="bibr" rid="CR11">11</xref>] and cortico-limbic structures [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>], with little effect on that within the cognitive control network (FPN) [<xref ref-type="bibr" rid="CR14">14</xref>]. However, there are few existing imaging studies of antidepressant treatment response and these have mainly examined limited sample sizes [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR15">15</xref>–<xref ref-type="bibr" rid="CR18">18</xref>]. The majority of these studies have also employed a pre-defined seed based connectivity analysis, which only considers a small subset of the brain [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. Although such a focused approach is useful to examine specific brain networks or specific neural connections, it limits a holistic and integrated systems level understanding of how these treatments affect the brain and its intrinsic functional networks. Finally, the primary focus for these previous studies has been on understanding the impact of antidepressants on neural changes and how these relate to changes in symptoms. Few studies have examined whether pre-treatment intrinsic neural characteristics may pre-dispose an individual to respond to antidepressant medications [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. Based on previous studies using both antidepressant medications and non-pharmaceutical treatments, there is some evidence to suggest that pre-treatment intrinsic brain connectivity, particularly related to the DMN, is associated with response to these treatments [<xref ref-type="bibr" rid="CR19">19</xref>–<xref ref-type="bibr" rid="CR21">21</xref>].</p>
              <p id="Par5">Here, we adopted a comprehensive, connectome-wide approach [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>] to investigate large-scale intrinsic functional brain networks that characterize remission to antidepressant medications prior to treatment in a cohort of 163 MDD patients. We analyzed intrinsic functional connectivity from fMRI scans collected prior to and following an 8-week course of randomly assigned one of three commonly prescribed first-line antidepressants in a practical clinical trial design. We also examined whether connectivity within the remission-related brain networks at baseline differs between MDD participants and healthy participants, whether it changes with treatment generally, and as a function of the specific medication used. Based on previous evidence, we hypothesized that pre-treatment functional connectivity related to the DMN is likely to characterize remitters from non-remitters, to differ between depressed and healthy individuals, and that DMN connectivity will also change following treatment. Our connectome-wide approach offers a powerful, comprehensive, and regionally unbiased way of examining the specificity of DMN connectivity.</p>
            </sec>
            <sec id="Sec2" sec-type="materials|methods">
              <title>Materials and methods</title>
              <sec id="Sec3">
                <title>Participants and study protocol</title>
                <p id="Par6">All participants that completed both the baseline and 8-week post-treatment fMRI scans from the imaging cohort of the iSPOT-D study were included in this analysis [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. Data were available for 163 MDD participants (out of the 204 that were recruited at baseline) and 62 age- and gender-matched healthy participants (CONSORT chart provided in Supplementary Fig. <xref rid="MOESM1" ref-type="media">S1</xref>). The iSPOT-D study protocol, clinical assessments and inclusion/exclusion criteria have been previously described [<xref ref-type="bibr" rid="CR25">25</xref>]. In short, the Mini-International Neuropsychiatric Interview [<xref ref-type="bibr" rid="CR26">26</xref>], according to DSM-IV criteria, and a 17-item Hamilton Rating Scale for Depression (HRSD<sub>17</sub>) [<xref ref-type="bibr" rid="CR27">27</xref>] score ≥16 confirmed the primary diagnosis of MDD. At baseline, all MDD participants were either antidepressant naïve or had undergone a washout period of at least five half-lives of a previously prescribed antidepressant medication. Healthy control participants were extensively screened for the absence of Axis I disorders and for an HRSD<sub>17</sub> score less than or equal to 7. MDD participants were randomized to receive flexibly dosed, open-label escitalopram, sertraline or venlafaxine-extended release (venlafaxine-XR) for 8 weeks at the end of which they completed the follow-up MRI session. Our study recruited from primary care, community, and academic psychiatry settings with the goal of representing a broad sample of antidepressant treatment seekers. Medications were prescribed and doses adjusted by treating clinicians according to routine clinical practice but following the recommended dose ranges. An HRSD<sub>17</sub> of ≤7 was used to define remission at week 8 (MDD-R: remitters and MDD-NR: non-remitters). In addition to the HRSD<sub>17</sub> score, participant age, gender, age of onset of depression, depression duration, number of previous depression episodes, previous treatment, melancholia, score of the 42 item depression-anxiety-stress scale (DASS) [<xref ref-type="bibr" rid="CR28">28</xref>] were recorded. Sample size was chosen as part of the original protocol development in order to achieve statistical power of 80% at an effect size of 1 standard deviation [<xref ref-type="bibr" rid="CR24">24</xref>]. Participants provided written informed consent in accordance with the ethical guidelines of the institutional review board (Western Sydney Local Health District Human Research Ethics Committee).</p>
              </sec>
              <sec id="Sec4">
                <title>fMRI acquisition, pre-processing, and generation of functional connectomes</title>
                <p id="Par7">Details of MRI acquisition, activation tasks, pre-processing, and intrinsic connectivity estimation were published previously [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR29">29</xref>] and can be found in Supplementary Section <xref rid="MOESM1" ref-type="media">S1</xref>. In brief, MRI data for both visits were acquired on a 3T GE Signa HDx scanner using an 8-channel head coil. MRI acquisition included five fMRI tasks (echo planar imaging; TR/TE = 2500/27.5 ms, Flip Angle = 90°, 64 × 64 matrix, 40 axial 3.5 mm slices, 120 volumes) and a 3D T1-weighted structural MRI scan (TR/TE = 8.3/3.2 ms, Flip Angle = 11°, TI = 500 ms, 256 × 256 matrix, 180 sagittal 1 mm slices). Intrinsic functional connectivity was estimated using data from all five tasks. fMRI images were motion-corrected and corrected for geometric distortions using realignment and unwarping, slice time corrected, spatially normalized to the stereotactic MNI space and smoothed. As motion is a critical issue in resting state data, data volumes associated with high movement (framewise displacement from one time point to the next) or changes in BOLD signal intensity were censored (temporally masked) to reduce the influence of motion and related artifacts [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. For each fMRI task, the BOLD responses for each experimental condition were modeled in the general linear model framework. Additional covariates for each task included the mean signal time course extracted from eroded ventricle and white matter masks, as well as the temporal masks derived from the volume censoring described above and motion effects using the Volterra expansion of the realignment parameters. To isolate an estimate of intrinsic functional connectivity, we regressed voxel-wise BOLD time series against the model incorporating task covariates as nuisance signals and analyzed the residuals of this model. Subsequent to this denoising procedure, the time-series were band-pass filtered (0.009 Hz &lt; <italic>f</italic> &lt; 0.08 Hz). Intrinsic connectivity estimated using this approach has been previously validated with task-free resting state connectivity [<xref ref-type="bibr" rid="CR32">32</xref>].</p>
                <p id="Par8">To generate whole-brain functional connectomes, we parcellated every individual’s brain image into 333 brain regions or nodes using a high-resolution template based on Gordon et al. [<xref ref-type="bibr" rid="CR33">33</xref>]. This template uses resting state functional connectivity patterns to define brain parcels that represent putative, functionally coherent, brain areas providing a label based on intrinsic functional brain networks. Intrinsic functional time series were extracted for each of the regions and correlated with every other region to obtain a 333 × 333 inter-regional functional connectivity matrix for every individual. We transformed the correlation coefficients into z-scores using Fisher’s z transformation. The specific choice of a parcellation scheme can impact the results of a network analysis [<xref ref-type="bibr" rid="CR34">34</xref>–<xref ref-type="bibr" rid="CR36">36</xref>]. To ensure that our findings are robust irrespective of choice of brain parcellation scheme, we also used a second anatomical parcellation based on the AAL atlas [<xref ref-type="bibr" rid="CR37">37</xref>] (reported in the supplement).</p>
              </sec>
              <sec id="Sec5">
                <title>Statistical analyses</title>
                <p id="Par9">The statistical analysis was designed in a step-wise manner to address study aims as follows.</p>
                <sec id="Sec6">
                  <title>1. To identify a connectome-based predicitive biomarker of antidepressant treatment outcome</title>
                  <p id="Par10">The Network Based Statistic (NBS) [<xref ref-type="bibr" rid="CR38">38</xref>] was used to assess differences in pre-treatment functional connectivity between MDD-R and MDD-NR participant groups taken across the three treatment arms. Analogous to cluster-based correction strategies used in voxel-wise MRI studies, the NBS deals with the multiple comparisons problem posed by connectomic data by evaluating the null hypothesis at the level of inter-connected sub-networks rather than individual connections. We first performed a two-sample <italic>t</italic>-test at each connection independently to test for significant differences in the value of connectivity between the two groups. A primary component-forming threshold (<italic>p</italic> &lt; .001) was applied to form a set of supra-threshold connections. Next, the size of the connected components in this thresholded network was computed. In this context, connected components are sets of nodes that can be linked by a set of supra-threshold connections. The statistical significance of the size of each observed component was then evaluated with respect to an empirical null distribution generated by randomly permuting the group membership of each individual, estimating the test statistic on the permuted data, storing the size of the largest component identified in the permuted data, and repeating the analysis (1000 permutations). A corrected <italic>p</italic>-value for each observed component was estimated as the proportion of null component sizes that was larger than the observed value. Observed components with <italic>p</italic> &lt; 0.05, component-wise corrected, were identified as significant sub-networks differentiating the two groups. Functional connectivity estimates for each connection of the identified sub-network were extracted.</p>
                  <p id="Par11">In supplementary analyses (Section <xref rid="MOESM1" ref-type="media">S2</xref>), we tested for associations between connectivity in this connectomic signature with demographic and clinical symptom measures and comparisons between MDD-R &amp; MDD-NR controlling for these measures. We also examined predictive models using this signature in classifying MDD-R/MDD-NR individuals and evaluate additive predictive value relative to demographic and clinical measures in a cross-validation framework (Supplementary Section <xref rid="MOESM1" ref-type="media">S3</xref>).</p>
                  <p id="Par12">For the analyses (2–4) below, we used a single connectivity estimate averaged across the significant connections for the identified network. We also computed an average connectivity estimate for each labeled intrinsic functional network pair combinations that characterized this network for the analyses below. To control for multiple testing due to number of measures, we employed a Benjamini-Hochberg FDR corrected <italic>p</italic> &lt; 0.05 for statistical evaluation.</p>
                </sec>
                <sec id="Sec7">
                  <title>2. Is the identified connectomic predictive biomarker differentially modulated by different medications?</title>
                  <p id="Par13">To test whether functional connectivity in the sub-network identified in analysis 1 is differentially associated with treatment outcome depending on antidepressant type, we used an analysis of variance (ANOVA) with two between-participants factors: treatment outcome (MDD-R/MDD-NR) and antidepressant type (with levels for the SSRIs escitalopram and sertraline, and the serotonin–norepinephrine reuptake inhibitor (SNRI) venlafaxine-XR). We tested for the interaction between outcome and antidepressant treatment type associated with functional connectivity.</p>
                </sec>
                <sec id="Sec8">
                  <title>3. Does the connectomic predictive biomarker also characterize MDD disease state at baseline?</title>
                  <p id="Par14">To test whether functional connectivity in the identified sub-network differs between MDD group as a whole from controls at baseline, we compared extracted connectivity measures using an ANOVA with group (MDD/control) as a between-participants factor. To identify other connectomic diagnostic signatures beyond the identified sub-network, we also performed an exploratory whole-brain connectivity comparison between the MDD and control groups using NBS (Supplementary analyses <xref rid="MOESM1" ref-type="media">S4</xref>).</p>
                </sec>
                <sec id="Sec9">
                  <title>4. Does the connectomic predictive biomarker change after 8 weeks of treatment (i.e. is also a response biomarker)?</title>
                  <p id="Par15">To test whether functional connectivity of the identified sub-network changed after treatment from baseline, we used an ANOVA with pre vs post follow-up (time) as a within-participants factor and group (with levels for MDD depending on treatment outcome i.e. MDD-R and MDD-NR, and controls) as a between-participants factor. We tested for the interaction between Pre–Post follow-up and group and also performed post hoc tests to characterize any significant interactions.</p>
                </sec>
              </sec>
            </sec>
            <sec id="Sec10" sec-type="results">
              <title>Results</title>
              <p id="Par16">Table <xref rid="Tab1" ref-type="table">1</xref> shows the demographic and clinical characteristics for remitters and non-remitter MDD participants. The remission rate for the sample was 35%.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Participant demographics and clinical characteristics</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>Controls (<italic>n</italic> = 62)</th><th>Remitters (<italic>n</italic> = 58)</th><th>Non-Remitters (<italic>n</italic> = 105)</th></tr></thead><tbody><tr><td>%Females</td><td>51%</td><td>51%</td><td>51%</td></tr><tr><td>Age (years)</td><td>31.4 ± 13.0</td><td>29.7 ± 8.7</td><td>36.6 ± 12.7</td></tr><tr><td>HRSD<sub>17</sub> baseline</td><td/><td>21.7 ± 4.0</td><td>21.8 ± 3.6</td></tr><tr><td>HRSD<sub>17</sub> week 8</td><td/><td>4.9 ± 1.7</td><td>13.3 ± 3.9</td></tr><tr><td>HRSD<sub>17</sub> %change</td><td/><td>77.3 ± 8.3</td><td>37.8 ± 19.2</td></tr><tr><td>Age of onset (years)</td><td/><td>19.7 ± 8.1</td><td>22.6 ± 10.7</td></tr><tr><td>MDD duration (years)</td><td/><td>9.5 ± 8.8</td><td>13.5 ± 12.2</td></tr><tr><td>Treatment naïve (%)</td><td/><td>64%</td><td>33%</td></tr><tr><td>Treatment arm (E/S/V)</td><td/><td>19/20/19</td><td>39/34/32</td></tr><tr><td>%MDD sample</td><td/><td>35%</td><td>65%</td></tr></tbody></table><table-wrap-foot><p><italic>HRSD</italic><sub><italic>17</italic></sub> 17-item Hamilton Rating Scale for Depression, <italic>MDD</italic> major depressive disorder, <italic>E</italic> Escitalopram, <italic>S</italic> Sertraline, <italic>V</italic> Venlafaxine-XR</p></table-wrap-foot></table-wrap></p>
              <sec id="Sec11">
                <title>Pre-treatment network differences in functional connectivity between MDD-R and MDD-NR</title>
                <p id="Par17">The NBS analysis identified a connectomic signature comprised of 86 connections across 59 nodes, which was significantly different in pre-treatment functional connectivity between MDD-R and MDD-NR (MDD-R &gt; MDD-NR; <italic>p</italic> = 0.021 corrected for multiple comparisons; Fig. <xref rid="Fig1" ref-type="fig">1</xref> and Table <xref rid="Tab2" ref-type="table">2</xref>). This connectomic signature was characterized by: (1) elevated intra-network intrinsic functional connectivity within the DMN (MDD-R &gt; MDD-NR) and (2) greater inter-network connectivity: (A) between regions of the DMN, fronto-parietal and somatomotor networks; (B) between regions of the DMN and visual, limbic, auditory, and ventral attention networks; and (C) between the fronto-parietal and somatomotor networks with cingulo-opercular and dorsal attention network regions (MDD-R &gt; MDD-NR). Connectivity was associated with age, gender, and treatment naivety, but remained significantly different between groups controlling for these measures. Average connectivity in this signature significantly improved predictive accuracy in classifying remitters from non-remitters compared to a model using demographic and clinical measures alone (<italic>p</italic> &lt; 0.001; Supplementary Table <xref rid="MOESM1" ref-type="media">S1</xref>: cross-validated accuracy of the model without connectivity/with connectivity = 61.5%/68.8%; sensitivity = 52.6%/63.1%; specificity = 72.4%/72.4%).<fig id="Fig1"><label>Fig. 1</label><caption><p>Pre-treatment connectome networks differentiating remitters from non-remitters. (top row) The connectomic feature identified from the NBS analysis. Node colors indicate intrinsic resting state brain network membership as defined by the Gordon et al. [<xref ref-type="bibr" rid="CR33">33</xref>] parcellation. (bottom row) The patterns of different intra- (loops) and inter-network connections comprising this feature (listed in Table <xref rid="Tab2" ref-type="table">2</xref>) are shown. The thickness of the lines correspond to the number of significant connections between networks of interests relative to the total number of possible connections i.e. thicker lines implies more number of significant connections between the networks. Bar plots (means and SD) showing average connectivity estimates at baseline and post-treatment for each group. There was a significant time*group interaction for average connectivity in this network feature. Asterisks indicate significant post hoc findings (<italic>p</italic> &lt; 0.05) for this interaction. DMN default mode network, FPN fronto-parietal network, SM somatomotor, VAN ventral attention network, DAN dorsal attention network, CON cingulo-opercular network, L left, R right, MDD-R Remitters, MDD-NR Non-remitters, Ctrl Healthy individuals</p></caption><graphic xlink:href="41380_2019_574_Fig1_HTML" id="d30e787"/></fig><table-wrap id="Tab2"><label>Table 2</label><caption><p>Pre-treatment functional connectivity differences between remitter and non-remitter groups using network-based statistical analysis</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Significant connections</th><th/><th/><th/><th colspan="2">Functional connectivity</th></tr><tr><th>Seed region</th><th>Coordinates (<italic>x</italic>,<italic>y</italic>,<italic>z</italic>)</th><th>Target region</th><th>Coordinates (<italic>x</italic>,<italic>y</italic>,<italic>z</italic>)</th><th>Remitters (<italic>N</italic> = 58)</th><th>Non-remitters (<italic>N</italic> = 105)</th></tr><tr><th/><th/><th/><th/><th>(Mean ± SD)</th><th>(Mean ± SD)</th></tr></thead><tbody><tr><td colspan="6"><italic>DMN-DMN (7 connections)</italic></td></tr><tr><td> L - Medial Superior Frontal Gyrus (BA9)</td><td>(−5.6, 42.2, 35.1)</td><td>L - Middle Frontal Gyrus (BA8)</td><td>(−41.7, 16.1, 47.5)</td><td>0.797 ± 0.245</td><td>0.643 ± 0.268</td></tr><tr><td> L - Medial Superior Frontal Gyrus (BA10)</td><td>(−6.5, 54.7, 18.1)</td><td>R - Mid Cingulum (BA24)</td><td>(3, −19.6, 37.9)</td><td>0.402 ± 0.273</td><td>0.247 ± 0.277</td></tr><tr><td> L - Medial Superior Frontal Gyrus (BA9)</td><td>(−6.5, 54.7, 18.1)</td><td>R - Middle Temporal Gyrus (BA21)</td><td>(57.5, −7.4, −16.4)</td><td>0.437 ± 0.236</td><td>0.266 ± 0.263</td></tr><tr><td> R - Medial Superior Frontal Gyrus (BA10)</td><td>(8.2, 53.8, 14)</td><td>R - Mid Cingulum (BA24)</td><td>(3, −19.6, 37.9)</td><td>0.418 ± 0.293</td><td>0.233 ± 0.318</td></tr><tr><td> R - Medial Superior Frontal Gyrus (BA9)</td><td>(6.8, 44.5, 34.8)</td><td>R - Middle Temporal Gyrus (BA21)</td><td>(62.5, −25.6, −5.5)</td><td>0.402 ± 0.239</td><td>0.252 ± 0.273</td></tr><tr><td> R - Superior Frontal Gyrus (BA8)</td><td>(13.8, 46.7, 42.1)</td><td>R - Middle Temporal Gyrus (BA21)</td><td>(57.5, −7.4, −16.4)</td><td>0.430 ± 0.226</td><td>0.270 ± 0.310</td></tr><tr><td colspan="6"><italic>DMN-FrontoParietal (5 connections)</italic></td></tr><tr><td> R - Mid Cingulum (BA24)</td><td>(3, −19.6, 37.9)</td><td>R - Superior Orbitofrontal Gyrus (BA10)</td><td>(28.4, 57, −5.1)</td><td>0.083 ± 0.160</td><td>−0.212 ± 0.231</td></tr><tr><td> L - Mid Cingulum (BA24)</td><td>(−1.7, −17.7, 39.1)</td><td>R - Superior Orbitofrontal Gyrus (BA10)</td><td>(28.4, 57, −5.1)</td><td>−0.108 ± 0.167</td><td>−0.236 ± 0.237</td></tr><tr><td> L - Mid Cingulum (BA24)</td><td>(−1.7, −17.7, 39.1)</td><td>R - Superior Frontal Gyrus (BA10)</td><td>(23.5, 59.1, 4.9)</td><td>−0.023 ± 0.190</td><td>−0.153 ± 0.240</td></tr><tr><td> R - Angular Gyrus</td><td>(48.9, −53, 28.6)</td><td>R - Superior Orbitofrontal Gyrus (BA10)</td><td>(28.4, 57, −5.1)</td><td>0.476 ± 0.272</td><td>0.311 ± 0.303</td></tr><tr><td> R - Middle Temporal Gyrus (BA21)</td><td>(62.5, −25.6, −5.5)</td><td>L - Superior Medial Frontal Gyrus (BA8)</td><td>(−5.5, 29.3, 44)</td><td>0.355 ± 0.220</td><td>0.219 ± 0.239</td></tr><tr><td colspan="6"><italic>DMN-Somatomotor (8 connections)</italic></td></tr><tr><td> L - Superior Medial Frontal Gyrus (BA9)</td><td>(−5.6, 42.2, 35.1)</td><td>R - Precentral Gyrus</td><td>(19.7, −25, 65.2)</td><td>0.007 ± 0.206</td><td>−0.127 ± 0.250</td></tr><tr><td> R - Superior Medial Frontal Gyrus (BA9)</td><td>(6.8, 44.5, 34.8)</td><td>R - Precentral Gyrus</td><td>(19.7, −25, 65.2)</td><td>0.022 ± 0.200</td><td>−0.104 ± 0.228</td></tr><tr><td> R - Superior Medial Frontal Gyrus (BA9)</td><td>(6.8, 44.5, 34.8)</td><td>R - Postcentral Gyrus</td><td>(11.9, −40.7, 67)</td><td>0.087 ± 0.239</td><td>−0.055 ± 0.244</td></tr><tr><td> R - Superior Medial Frontal Gyrus (BA9/10)</td><td>(6.8, 44.5, 34.8)</td><td>R - Paracentral Lobule</td><td>(4.8, −27.1, 64.8)</td><td>0.085 ± 0.223</td><td>−0.063 ± 0.272</td></tr><tr><td colspan="6"><italic>DMN-Visual (6 connections)</italic></td></tr><tr><td> R - Superior Frontal Gyrus (BA8)</td><td>(13.8, 46.7, 42.1)</td><td>L - Lingual Gyrus (BA18)</td><td>(−22, −58.1, 1.5)</td><td>0.171 ± 0.231</td><td>0.013 ± 0.267</td></tr><tr><td> R - Superior Frontal Gyrus (BA8)</td><td>(13.8, 46.7, 42.1)</td><td>R - Parahippocampal Gyrus (BA19)</td><td>(19.6, −45.3, −4.4)</td><td>0.106 ± 0.198</td><td>−0.020 ± 0.236</td></tr><tr><td> R - Medial Superior Frontal Gyrus (BA9)</td><td>(5.9, 54.9, 29.4)</td><td>L - Fusiform Gyrus</td><td>(−28.8, −58.8, −9.1)</td><td>−0.011 ± 0.192</td><td>−0.145 ± 0.216</td></tr><tr><td> R - Medial Superior Frontal Gyrus (BA9)</td><td>(5.9, 54.9, 29.4)</td><td>R - Lingual Gyrus</td><td>(22.3, −46.5, −9.9)</td><td>0.067 ± 0.193</td><td>−0.062 ± 0.236</td></tr><tr><td colspan="6"><italic>DMN-Limbic (3 connections)</italic></td></tr><tr><td> R - Superior Frontal Gyrus (BA8)</td><td>(21, 32.8, 41.1)</td><td>R - Hippocampus</td><td>(24.9, −35.9, −4.8)</td><td>0.012 ± 0.186</td><td>−0.094 ± 0.192</td></tr><tr><td colspan="6"><italic>DMN-Auditory (1 connection)</italic></td></tr><tr><td> L - Medial Superior Frontal Gyrus (BA9)</td><td>(−5.6, 42.2, 35.1)</td><td>R - Superior Temporal Gyrus (BA22)</td><td>(61.7, −24, 1.3)</td><td>0.082 ± 0.188</td><td>−0.050 ± 0.247</td></tr><tr><td colspan="6"><italic>DMN-Ventral Attention (1 connection)</italic></td></tr><tr><td> L - Medial Superior Frontal Gyrus (BA9)</td><td>(−5.6, 42.2, 35.1)</td><td>L - Middle Temporal Gyrus (BA22)</td><td>(−48.1, −40, 2.4)</td><td>0.200 ± 0.245</td><td>0.043 ± 0.278</td></tr><tr><td colspan="6"><italic>DMN-Unspecified Network (1 connection)</italic></td></tr><tr><td> L - Medial Superior Frontal Gyrus (BA9)</td><td>(−5.6, 42.2, 35.1)</td><td>L - Superior Temporal Pole (BA38)</td><td>(−33.6, 17.2, −31.5)</td><td>0.218 ± 0.214</td><td>0.090 ± 0.234</td></tr><tr><td colspan="6"><italic>FrontoParietal-Somatomotor (36 connections)</italic></td></tr><tr><td> R - Superior Frontal Gyrus (BA10)</td><td>(30.9, 52.2, 9.9)</td><td>L - Supplementary Motor Area</td><td>(−5.4, −15.9, 48.8)</td><td>−0.040 ± 0.193</td><td>−0.182 ± 0.273</td></tr><tr><td> R - Superior Frontal Gyrus (BA10)</td><td>(30.9, 52.2, 9.9)</td><td>L - Precentral Gyrus</td><td>(−20.5, −24.9, 64.5)</td><td>−0.122 ± 0.200</td><td>−0.248 ± 0.225</td></tr><tr><td> R - Superior Frontal Gyrus (BA10)</td><td>(30.9, 52.2, 9.9)</td><td>R - Precentral Gyrus</td><td>(19.7, −25, 65.2)</td><td>−0.108 ± 0.224</td><td>−0.277 ± 0.200</td></tr><tr><td> R - Superior Frontal Gyrus (BA10)</td><td>(30.9, 52.2, 9.9)</td><td>L - Postcentral Gyrus</td><td>(−35.2, −35.3, 42)</td><td>0.028 ± 0.203</td><td>−0.101 ± 0.225</td></tr><tr><td> R - Superior Frontal Gyrus (BA10)</td><td>(30.9, 52.2, 9.9)</td><td>R - Postcentral Gyrus</td><td>(28, −34.8, 63.1)</td><td>−0.157 ± 0.241</td><td>−0.312 ± 0.237</td></tr><tr><td> R - Superior Frontal Gyrus (BA10)</td><td>(30.9, 52.2, 9.9)</td><td>R - Inferior Parietal Gyrus</td><td>(34.2, −40.6, 51.6)</td><td>−0.053 ± 0.207</td><td>−0.229 ± 0.246</td></tr><tr><td> R - Middle Frontal Gyrus</td><td>(38.1, 45.9, 7.7)</td><td>R - Precentral Gyrus</td><td>(19.7, −25, 65.2)</td><td>−0.079 ± 0.180</td><td>−0.209 ± 0.180</td></tr><tr><td> R - Middle Frontal Gyrus</td><td>(38.1, 45.9, 7.7)</td><td>R - Postcentral Gyrus</td><td>(28, −34.8, 63.1)</td><td>−0.097 ± 0.224</td><td>−0.224 ± 0.204</td></tr><tr><td> R - Middle Frontal Gyrus</td><td>(38.1, 45.9, 7.7)</td><td>R − Inferior Parietal Gyrus</td><td>(34.2, −40.6, 51.6)</td><td>0.009 ± 0.197</td><td>−0.114 ± 0.212</td></tr><tr><td> R - Medial Superior Frontal Gyrus (BA8)</td><td>(7, 25.7, 47.3)</td><td>R - Precentral Gyrus</td><td>(16.5, −32.8, 67.7)</td><td>−0.003 ± 0.233</td><td>−0.128 ± 0.216</td></tr><tr><td> R - Medial Superior Frontal Gyrus (BA8)</td><td>(7, 25.7, 47.3)</td><td>R - Postcentral Gyrus</td><td>(11.9, −40.7, 67)</td><td>0.100 ± 0.229</td><td>−0.034 ± 0.216</td></tr><tr><td> R - Medial Superior Frontal Gyrus (BA8)</td><td>(7, 25.7, 47.3)</td><td>R - Paracentral Lobule</td><td>(4.8, −27.1, 64.8)</td><td>0.180 ± 0.217</td><td>0.046 ± 0.208</td></tr><tr><td> R - Superior Orbitofrontal Gyrus (BA10)</td><td>(28.4, 57, −5.1)</td><td>R - Precentral Gyrus</td><td>(16.5, −32.8, 67.7)</td><td>−0.100 ± 0.186</td><td>−0.226 ± 0.218</td></tr><tr><td> R - Superior Orbitofrontal Gyrus (BA10)</td><td>(28.4, 57, −5.1)</td><td>R - Postcentral Gyrus</td><td>(9.5, −42.5, 60.4)</td><td>−0.147 ± 0.198</td><td>−0.270 ± 0.224</td></tr><tr><td> R - Superior Orbitofrontal Gyrus (BA10)</td><td>(28.4, 57, −5.1)</td><td>L - Paracentral Lobule</td><td>(−5, −28.2, 60.4)</td><td>−0.017 ± 0.186</td><td>−0.163 ± 0.276</td></tr><tr><td> R - Superior Orbitofrontal Gyrus (BA10)</td><td>(28.4, 57, −5.1)</td><td>R - Paracentral Lobule</td><td>(4.8, −27.1, 64.8)</td><td>0.026 ± 0.222</td><td>−0.125 ± 0.265</td></tr><tr><td> R - Superior Orbitofrontal Gyrus (BA10)</td><td>(28.4, 57, −5.1)</td><td>L - Superior Parietal Gyrus (BA5)</td><td>(−28.6, −44.7, 61.7)</td><td>−0.156 ± 0.179</td><td>−0.273 ± 0.196</td></tr><tr><td> R - Superior Orbitofrontal Gyrus (BA10)</td><td>(28.4, 57, −5.1)</td><td>R - Inferior Parietal Gyrus (BA40)</td><td>(34.2, −40.6, 51.6)</td><td>−0.098 ± 0.186</td><td>−0.239 ± 0.219</td></tr><tr><td> L - Middle Frontal Gyrus (BA10)</td><td>(−28.6, 50.9, 10.1)</td><td>R - Precentral Gyrus</td><td>(19.7, −25, 65.2)</td><td>−0.101 ± 0.196</td><td>−0.222 ± 0.216</td></tr><tr><td> R - Inferior Frontal Orbitalis</td><td>(42.8, 48.3, −5.1)</td><td>R - Precentral Gyrus</td><td>(19.7, −25, 65.2)</td><td>−0.051 ± 0.170</td><td>−0.171 ± 0.215</td></tr><tr><td colspan="6"><italic>FrontoParietal-CinguloOpercular (7 connections)</italic></td></tr><tr><td> R - Superior Frontal Gyrus (BA10)</td><td>(30.9, 52.2, 9.9)</td><td>L - Mid Cingulum (BA31)</td><td>(−16.6, −36.1, 42.7)</td><td>−0.127 ± 0.189</td><td>−0.258 ± 0.228</td></tr><tr><td> R - Superior Frontal Gyrus (BA10)</td><td>(30.9, 52.2, 9.9)</td><td>R - Mid Cingulum (BA31)</td><td>(16.2, −33.1, 43.2)</td><td>−0.118 ± 0.193</td><td>−0.256 ± 0.215</td></tr><tr><td> R - Superior Orbitofrontal Gyrus (BA10)</td><td>(28.4, 57, −5.1)</td><td>L - Mid Cingulum (BA31)</td><td>(−16.6, −36.1, 42.7)</td><td>−0.155 ± 0.175</td><td>−0.300 ± 0.211</td></tr><tr><td> R - Superior Orbitofrontal Gyrus (BA10)</td><td>(28.4, 57, −5.1)</td><td>R - Mid Cingulum (BA31)</td><td>(16.2, −33.1, 43.2)</td><td>−0.144 ± 0.175</td><td>−0.299 ± 0.211</td></tr><tr><td> R - Middle Frontal Gyrus</td><td>(38.1, 45.9, 7.7)</td><td>R - Mid Cingulum (BA31)</td><td>(16.2, −33.1, 43.2)</td><td>−0.003 ± 0.230</td><td>−0.132 ± 0.203</td></tr><tr><td colspan="6"><italic>FrontoParietal-Dorsal Attention (4 connections)</italic></td></tr><tr><td> R - Superior Frontal Gyrus (BA10)</td><td>(30.9, 52.2, 9.9)</td><td>R - Inferior Parietal Gyrus (BA40)</td><td>(33.5, −48.2, 49.4)</td><td>−0.081 ± 0.181</td><td>−0.238 ± 0.293</td></tr><tr><td> R - Superior Orbitofrontal Gyrus (BA10)</td><td>(28.4, 57, −5.1)</td><td>R - Inferior Parietal Gyrus (BA40)</td><td>(33.5, −48.2, 49.4)</td><td>−0.003 ± 0.195</td><td>−0.184 ± 0.287</td></tr><tr><td> R - Superior Orbitofrontal Gyrus (BA10)</td><td>(28.4, 57, −5.1)</td><td>L - Inferior Parietal Gyrus (BA40)</td><td>(−31.1, −48.9, 47.1)</td><td>−0.085 ± 0.187</td><td>−0.217 ± 0.247</td></tr><tr><td colspan="6"><italic>Somatomotor-CinguloOpercular (3 connections)</italic></td></tr><tr><td> R - Precentral Gyrus</td><td>(19.7, −25, 65.2)</td><td>R - Middle Frontal Gyrus (BA10)</td><td>(31.3, 39.7, 25.6)</td><td>−0.076 ± 0.197</td><td>−0.204 ± 0.211</td></tr><tr><td colspan="6"><italic>Somatomotor-Ventral Attention (2 connections)</italic></td></tr><tr><td> L - Postcentral Gyrus</td><td>(−41.5, −12.5 50.4)</td><td>L - Inferior Frontal Triangularis (BA47)</td><td>(−45.4, 28.8, 0.8)</td><td>0.150 ± 0.222</td><td>0.029 ± 0.205</td></tr><tr><td> R - Paracentral Lobule</td><td>(4.8, −27.1, 64.8)</td><td>R - Inferior Frontal Orbitalis (BA47)</td><td>(48.1, 38.3, −9.2)</td><td>0.160 ± 0.158</td><td>0.024 ± 0.263</td></tr><tr><td colspan="6"><italic>Somatomotor-Dorsal Attention (1 connection)</italic></td></tr><tr><td> R - Precentral Gyrus</td><td>(19.7, −25, 65.2)</td><td>R - Middle Frontal Gyrus (BA10)</td><td>(36.8, 37.8, 13.1)</td><td>−0.070 ± 0.185</td><td>−0.192 ± 0.213</td></tr><tr><td colspan="6"><italic>CinguloOpercular–CinguloOpercular (1 connection)</italic></td></tr><tr><td> R - Middle Frontal Gyrus (BA10)</td><td>(31.3, 39.7, 25.6)</td><td>R - Mid Cingulum (BA31)</td><td>(16.2, −33.1, 43.2)</td><td>0.150 ± 0.295</td><td>−0.004 ± 0.249</td></tr></tbody></table><table-wrap-foot><p>The seed and target regions for the significant connections from this identified connectomic network were defined as belonging to the intrinsic functional brain networks based on the established parcellation template of Gordon et al. [<xref ref-type="bibr" rid="CR33">33</xref>] rather than by anatomical boundaries (which means that an anatomical region could have membership for multiple intrinsic functional network due to multiple nodes representing the region). Fifteen unique network-pair combinations were identified and are listed. Mean and standard deviations for the resting functional connectivity estimates for the different connections are summarized</p></table-wrap-foot></table-wrap></p>
              </sec>
              <sec id="Sec12">
                <title>Is this connectomic predictive biomarker differentially associated with outcome depending on type of antidepressant?</title>
                <p id="Par18">There were no significant interactions between treatment outcome and type of antidepressant or main effect of antidepressant for connectivity measures for this signature, suggesting this biomarker to be associated with a general response to the three antidepressant medications.</p>
              </sec>
              <sec id="Sec13">
                <title>Does the connectomic predictive biomarker also characterize MDD disease state at baseline?</title>
                <p id="Par19">At baseline, controls were not significantly different compared to the whole MDD cohort for average connectivity in this signature (<italic>p</italic> = 0.078). However, controls had significantly greater connectivity compared to MDD only in the DMN-frontoparietal connections of this signature (FDRp &lt; 0.05).</p>
              </sec>
              <sec id="Sec14">
                <title>Does this connectomic predictive biomarker change after 8-week antidepressant treatment?</title>
                <p id="Par20">A significant group*time interaction was observed for average connectivity in this signature (<italic>p</italic> = 0.011) and specifically only for connections between the somatomotor and ventral attention networks (FDRp &lt; 0.05; Table <xref rid="Tab3" ref-type="table">3</xref> and Fig. <xref rid="Fig2" ref-type="fig">2</xref>). Post hoc contrasts indicated a significant increase of functional connectivity with treatment only for MDD-NR (controls and MDD-R remain unchanged). At baseline, MDD-NR had significantly lower connectivity relative to both MDD-R and controls. Post-treatment, although connectivity had normalized (i.e., there was no significant difference relative to controls), MDD-NR still had a significantly lower average connectivity in the signature than MDD-R. On the other hand, MDD-R had a significantly higher average connectivity in this signature relative to controls at both pre- and post-treatment. For the somatomotor-ventral attention connectivity, MDD-R were not significantly different than controls at both time-points and also relative to MDD-NR at post-treatment.<table-wrap id="Tab3"><label>Table 3</label><caption><p>Change in functional connectivity following 8 weeks of antidepressant treatment</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3">Networks</th><th colspan="6">Functional connectivity (Mean ± SD)</th><th colspan="10"><italic>p</italic> values</th></tr><tr><th colspan="2">Ctrl</th><th colspan="2">MDD-R</th><th colspan="2">MDD-NR</th><th>Time*Group</th><th colspan="3">Main effect time (Baseline vs Post)</th><th colspan="3">Baseline only—between group (age controlled)</th><th colspan="3">Post Tx only—between group (age controlled)</th></tr><tr><th>Baseline</th><th>Post</th><th>Baseline</th><th>Post</th><th>Baseline</th><th>Post</th><th/><th>MDD-R</th><th>MDD-NR</th><th>Ctrl</th><th>MDD-R &gt; MDD-NR</th><th>MDD-NR&lt;Ctrl</th><th>MDD-R &gt; Ctrl</th><th>MDD-R &gt; MDD-NR</th><th>MDD-NR&lt;Ctrl</th><th>MDD-R &gt; Ctrl</th></tr></thead><tbody><tr><td>Whole network</td><td>−0.039 ± 0.099</td><td>−0.042 ± 0.106</td><td>0.034 ± 0.103</td><td>0.026 ± 0.096</td><td>−0.117 ± 0.142</td><td>−0.071 ± 0.125</td><td>0.011</td><td>NS</td><td>0.003</td><td>NS</td><td>&lt;0.001</td><td>0.001</td><td>0.011</td><td>&lt;0.001</td><td>NS</td><td>0.002</td></tr><tr><td>DMN-FrontoParietal</td><td>0.107 ± 0.158</td><td>0.079 ± 0.166</td><td>0.121 ± 0.125</td><td>0.130 ± 0.140</td><td>−0.014 ± 0.186</td><td>0.020 ± 0.144</td><td>0.031</td><td>NS</td><td>0.045</td><td>NS</td><td>&lt;0.001</td><td>&lt;.001</td><td>NS</td><td>&lt;0.001</td><td>NS</td><td>0.049</td></tr><tr><td>DMN-Somatomotor</td><td>−0.010 ± 0.177</td><td>0.016 ± 0.178</td><td>0.052 ± 0.188</td><td>0.028 ± 0.201</td><td>−0.099 ± 0.196</td><td>−0.044 ± 0.182</td><td>0.014</td><td>NS</td><td>0.002</td><td>NS</td><td>0.001</td><td>0.022</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td></tr><tr><td>FrontoParietal-Somatomotor</td><td>−0.141 ± 0.117</td><td>−0.158 ± 0.128</td><td>−0.064 ± 0.138</td><td>−0.071 ± 0.127</td><td>−0.211 ± 0.163</td><td>−0.164 ± 0.145</td><td>0.016</td><td>NS</td><td>0.008</td><td>NS</td><td>&lt;0.001</td><td>0.009</td><td>0.024</td><td>0.001</td><td>NS</td><td>0.001</td></tr><tr><td>FrontoParietal-Dorsal Attention</td><td>−0.077 ± 0.223</td><td>−0.112 ± 0.185</td><td>−0.016 ± 0.176</td><td>−0.019 ± 0.165</td><td>−0.194 ± 0.271</td><td>−0.134 ± 0.217</td><td>0.015</td><td>NS</td><td>0.019</td><td>NS</td><td>&lt;0.001</td><td>0.008</td><td>NS</td><td>0.007</td><td>NS</td><td>0.018</td></tr><tr><td>Somatomotor-Ventral Attention</td><td>0.105 ± 0.154</td><td>0.129 ± 0.176</td><td>0.156 ± 0.156</td><td>0.146 ± 0.156</td><td>0.027 ± 0.187</td><td>0.101 ± 0.167</td><td>0.003*</td><td>NS</td><td>&lt;0.001</td><td>NS</td><td>0.001</td><td>0.034</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td></tr></tbody></table><table-wrap-foot><p>Network connections with a significant Time*Group interaction are listed. (*Significant at FDR corrected <italic>p</italic> &lt; 0.05)</p></table-wrap-foot></table-wrap><fig id="Fig2"><label>Fig. 2</label><caption><p>Intra- and inter-network connections that differentiate Remitters from Non-Remitters. Bar plots show connectivity estimates at baseline and post-treatment (means and SD). There was a significant time*group interaction (FDRp &lt; 0.05) only for the somatomotor-ventral attention connections. Asterisks indicate significant post hoc findings (<italic>p</italic> &lt; 0.05) for this interaction. DMN default mode network, FPN fronto-parietal network, SM somatomotor, VAN ventral attention network, DAN dorsal attention network, CON cingulo-opercular network, L left, R right, MDD-R Remitters, MDD-NR Non-Remitters, Ctrl Healthy individuals</p></caption><graphic xlink:href="41380_2019_574_Fig2_HTML" id="d30e2491"/></fig></p>
              </sec>
            </sec>
            <sec id="Sec15" sec-type="discussion">
              <title>Discussion</title>
              <p id="Par21">Using a comprehensive, connectome-wide analysis, we examined pre-treatment intrinsic functional connectivity associated with remission after 8 weeks of treatment with one of three commonly prescribed antidepressants: two selective serotonin reuptake inhibitors (escitalopram and sertraline) and a combined serotonin and norepinephrine reuptake inhibitor (venlafaxine-XR).</p>
              <p id="Par22">Our study focuses on large-scale intrinsic brain networks that play a key role in diverse cognitive, emotional, and self-reflective functions [<xref ref-type="bibr" rid="CR7">7</xref>] and sheds light on network-level connectivity in a sample powered to stratify by remission status and different antidepressant types. Patients with an overall greater than normal connectivity, particularly related to the DMN, fronto-parietal and somatomotor brain networks, were the most likely to benefit from antidepressant treatment and to achieve acute remission. This finding was especially striking given that, as a total group, depressed patients were characterized by a connectomic signature of lower connectivity compared to controls at the pre-treatment baseline (Supplementary Fig. <xref rid="MOESM1" ref-type="media">S2</xref> and Table <xref rid="MOESM1" ref-type="media">S2</xref>). This finding was robust to the method used to define these networks (Supplementary Fig. <xref rid="MOESM1" ref-type="media">S3</xref> and Table <xref rid="MOESM1" ref-type="media">S3</xref>). The new insights from this analysis suggest that clinical remission may in fact require intact or greater than normal pre-treatment inter-network intrinsic connectivity, rather than reflect a shift from abnormal to normal connectivity. This effect appears especially salient for brain networks associated with awareness of self and cognitive control.</p>
              <p id="Par23">The DMN is the network of the brain that focuses on internal mental states and its activity is often anti-correlated with other intrinsic networks involved in attending to functions such as attentional vigilance and orienting [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. This interplay between the DMN with other brain networks and its relation to antidepressant treatment response has been of interest in previous work using electroencephalography. Using a LORETA analysis with a region of interest approach, Whitton and colleagues [<xref ref-type="bibr" rid="CR41">41</xref>] evaluated whether activation of the rostral anterior cingulate cortex (rACC) shows phase lagged synchronization with other cortical regions in the beta and theta frequency bands. They found that synchrony of the rACC and anterior insula within the theta band is a prospective non-specific marker of response to both sertraline and placebo. Our study complements and builds on this knowledge in several ways. We use a different methodology based on functional MRI applied in a connectome-wide approach to evaluate intrinsic functional connectivity across networks. We deploy this methodology in a biomarker trial comparing sertraline to two other active antidepressant treatments. In addition, we evaluate change in functional connectivity post-treatment and compared this change to a normative framework of healthy subject connectivity over the same time period. Our findings indicate that connectivity related to the DMN is a prognostic marker of remission across all three treatments. Thus, our findings add weight to the possibility that connectivity or synchronization, assessed both regionally and brain-wide, and with different methodologies, may be an important general marker of antidepressant treatment outcomes. Our findings also support previous reports of functional and structural connectivity of the DMN to be associated with antidepressant treatment outcomes in depression [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR42">42</xref>–<xref ref-type="bibr" rid="CR44">44</xref>]. Non-remitters in our study showed abnormally reduced average functional connectivity in our connectomic signature. This is consistent with previous findings that also observed similar low pre-treatment functional connectivity, though restricted to the cognitive control network, to be associated with non-remission to escitalopram in older depressed cohorts [<xref ref-type="bibr" rid="CR16">16</xref>]. Our findings however contradict previous reports that treatment resistant patients show hyper-connectivity within the DMN compared to those who respond to treatment [<xref ref-type="bibr" rid="CR45">45</xref>]. However, previous studies have typically measured response (i.e. symptom improvement), rather than remission and have relied on limited sample sizes. While response may reflect an immediate relief of symptoms, achieving remission is the ultimate goal of treatment. This inconsistency in direction of findings could also possibly be because previous studies have utilized resting state fMRI whereas our study derived intrinsic connectivity from task-based fMRI scans after removing task residuals. These differences may be related to task effects not fully captured by the task regressors, or more simply differences in pre-processing strategies implemented by different studies [<xref ref-type="bibr" rid="CR46">46</xref>]. It is likely that the observed increases in connectivity with the DMN may represent diminished task-induced deactivation of this network, and vice versa, which would suggest that the group differences could be related to differences in attentional engagement rather than solely due to internal rumination.</p>
              <p id="Par24">Our data also provide insight into the impact of medications on neural connectivity. Previous studies have observed an increase [<xref ref-type="bibr" rid="CR47">47</xref>], decrease [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR17">17</xref>] or both [<xref ref-type="bibr" rid="CR48">48</xref>] in resting functional connectivity due to antidepressant medications. Our MDD cohort overall had a significant increase in connectivity (averaged over the identified predictive connectomic signature) from baseline with normalization at post-treatment. However, on splitting the group based on outcome, only non-remitters showed an increase in connectivity at the follow-up scan. While this was reflected in average connectivity across the predictive connectomic signature, this effect was found strongest for connectivity between the inferior frontal regions of the VAN and post-central gyral regions of the somatomotor network. Depression is characterized by deficits in reorienting attention to salient events and these results suggest the role of antidepressants in possibly targeting connections relevant in relaying information about salience and somatosensation [<xref ref-type="bibr" rid="CR8">8</xref>]. For these patients who did not remit in the acute phase of focus in this study, there was also a lack of correlation between change in connectivity and change in symptoms, consistent with their non-remitting status (supplementary results). It remains possible that these participants are on a trajectory to remit over a longer time scale (subsequent to the increase in connectivity), which requires future investigation. Remitters (and controls), on the other hand, exhibited consistent connectivity across baseline and follow-up scans. This observation is important for developing a mechanistic understanding of how connectivity relates to clinical outcome. In this case, it appears that “acute” remission depends on the pre-existence of higher than normal levels of intrinsic network organization, particularly for regions critical in top-down control of attention and emotions which are often found to be underlying impaired cognitive and emotion processing abilities in depression [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]. Without this, the brain may be unable to mount the plastic change required for clinical change. Although we would presume that any clinical change (symptom improvement or remission) would necessitate an underlying change at the neural level, this may not be true for intrinsic functional connectivity. It is possible that task-elicited neural changes are more directly related to the clinical change over and above the intact underlying intrinsic organization of what is occurring at rest [<xref ref-type="bibr" rid="CR50">50</xref>]. However, this possibility requires systematic investigation, particularly as there is a dearth of studies that have evaluated how changes in resting connectivity relate to improvement in symptoms following antidepressant medication treatments. One reason for discrepant results may be the use of task residuals in our study, although there is strong similarity between resting and residual brain networks [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR51">51</xref>]. Future studies should also evaluate differential contributions of resting and task-related functional connectivity.</p>
              <p id="Par25">Our study also provides evidence on how intrinsic connectivity relates to outcome from different types of antidepressants. To the best of our knowledge, no previous study has compared effect of different types of antidepressants on intrinsic functional connectivity measures. In our study, MDD participants were randomized to one of three commonly used antidepressants in primary care settings. The connectomic signature identified in our study appears to be associated with a general response to antidepressant medications and we did not observe connectivity differences associated with the three antidepressants used. This could suggest that greater than normal intrinsic organization is likely a necessary moderator of broad types of drug treatments of depression. Although this remains to be tested in medications beyond the ones used in our study. Clinically this could mean that MDD patients with an abnormally reduced intrinsic connectivity are less likely to benefit acutely from antidepressant medications as first-line treatments. Whether these patients could benefit from an alternative treatment regime that normalizes this DMN connectivity prior to or in conjunction with antidepressants is worthy of future investigations.</p>
              <p id="Par26">Our findings are limited to the three commonly prescribed antidepressant medications used in the study, and the generalizability of these findings to other classes of antidepressants currently available needs to be validated. Our study also lacked a placebo arm, which limits our ability to differentiate the specific effects of antidepressant therapy from spontaneous remission. Previous findings have identified a role for resting-state connectivity in predicting placebo effects [<xref ref-type="bibr" rid="CR15">15</xref>]. We also included participants who were medication naïve or had previous history of antidepressant use. Although our network findings were significant, even after controlling for previous treatment in our analysis and patients on existing treatments underwent a washout phase prior to enrolling in the current study, any bias due to effects of previous treatments on current antidepressant action cannot be ruled out. We performed cross-validation classification analyses to predict treatment outcome mainly to identify the best predictive model features and provide an operational example of how neural measures we identified could be helpful in treatment decision. Despite our respectable sample size relative to prior studies investigating neural predictors of antidepressant treatment and we used cross-validation statistics, these findings can only be considered preliminary without replication in an independent cohort. Integration of both task-evoked and intrinsic functional connectivity will be an interesting avenue of future investigation [<xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR53">53</xref>].</p>
              <p id="Par27">The use of connectomics to identify novel brain networks in diagnosis and prognosis of psychiatric disorders is a major methodological step forward. Using this approach, we have identified the intrinsic brain networks underlying acute non-remission to antidepressants. Greater than normal connectivity within these networks may be a prerequisite mechanism for recovery on antidepressant medications. This identified connectomic signature holds potential as a prognostic marker in the clinical management of depression.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supplementary information</title>
              <sec id="Sec16">
                <p>
                  <supplementary-material content-type="local-data" id="MOESM1">
                    <media xlink:href="41380_2019_574_MOESM1_ESM.docx">
                      <caption>
                        <p>Supplementary Section</p>
                      </caption>
                    </media>
                  </supplementary-material>
                </p>
              </sec>
            </sec>
          </body>
          <back>
            <fn-group>
              <fn>
                <p>Trial Registration: Registry Name: ClinicalTrials.gov; Registration Number: NCT00693849; URL: <ext-link ext-link-type="uri" xlink:href="http://www.clinicaltrials.gov/ct2/show/NCT00693849?term=iSPOT-D&amp;rank=1">http://www.clinicaltrials.gov/ct2/show/NCT00693849?term=iSPOT-D&amp;rank=1</ext-link></p>
              </fn>
              <fn>
                <p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
              </fn>
            </fn-group>
            <sec>
              <title>Supplementary information</title>
              <p>The online version of this article (10.1038/s41380-019-0574-2) contains supplementary material, which is available to authorized users.</p>
            </sec>
            <ack>
              <title>Acknowledgements</title>
              <p>The authors acknowledge Brain Resource Ltd as the sponsor for the iSPOT-D study (NCT00693849). The authors acknowledge the role of Prof Anthony Harris and Prof Tim Usherwood as clinical PIs and their role for overseeing the clinical testing and recruitment for the Sydney site for the study. The authors also acknowledge the role of Dr. Claire Day as Global Study coordinator and thank the iSPOT-D Publication Team for their valuable input to the study overall. The authors thank Prof Stuart Grieve, Dr. Lavier Gomes, Ms. Sheryl Foster and the Department of Radiology at Westmead Hospital for their substantial contributions to MRI data acquisition and other contributions to the imaging component of the iSPOT-D study. M.S.K. was supported by a National Health and Medical Research Council of Australia Career Development Fellowship (APP1090148). A.F. was supported by the Sylvia and Charles Viertel Foundation. L.M.W. was supported by the National Institutes of Health (U01MH109985).</p>
            </ack>
            <notes notes-type="ethics">
              <title>Compliance with ethical standards</title>
              <notes id="FPar1" notes-type="COI-statement">
                <title>Conflict of interest</title>
                <p id="Par28">L.M.W. has received consultant fees from BlackThorn Therapeutics. She has also received scientific advisory board fees from Psyberguide of the One Mind Institute. M.S.K., A.G.P., A.F. have no financial disclosures related to the work.</p>
              </notes>
            </notes>
            <ref-list id="Bib1">
              <title>References</title>
              <ref id="CR1">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Koenig</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Thase</surname>
                      <given-names>ME</given-names>
                    </name>
                  </person-group>
                  <article-title>First-line pharmacotherapies for depression—what is the best choice?</article-title>
                  <source>Polskie Archiwum Med Wewnetrznej</source>
                  <year>2009</year>
                  <volume>119</volume>
                  <fpage>478</fpage>
                  <lpage>86.</lpage>
                </element-citation>
              </ref>
              <ref id="CR2">
                <label>2.</label>
                <mixed-citation publication-type="other">American Psychiatric Association. American Psychiatric Association: Practice guideline for the treatment of patients with major depressive disorder. 3rd ed. 2010; <ext-link ext-link-type="uri" xlink:href="http://psychiatryonline.org/guidelines.aspx">http://psychiatryonline.org/guidelines.aspx</ext-link>. Accessed 17 Apr 2012.</mixed-citation>
              </ref>
              <ref id="CR3">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rush</surname>
                      <given-names>AJ</given-names>
                    </name>
                    <name>
                      <surname>Trivedi</surname>
                      <given-names>MH</given-names>
                    </name>
                    <name>
                      <surname>Wisniewski</surname>
                      <given-names>SR</given-names>
                    </name>
                    <name>
                      <surname>Nierenberg</surname>
                      <given-names>AA</given-names>
                    </name>
                    <name>
                      <surname>Stewart</surname>
                      <given-names>JW</given-names>
                    </name>
                    <name>
                      <surname>Warden</surname>
                      <given-names>D</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report</article-title>
                  <source>Am J Psychiatry</source>
                  <year>2006</year>
                  <volume>163</volume>
                  <fpage>1905</fpage>
                  <lpage>17</lpage>
                  <?supplied-pmid 17074942?>
                  <pub-id pub-id-type="pmid">17074942</pub-id>
                </element-citation>
              </ref>
              <ref id="CR4">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Saveanu</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Etkin</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Duchemin</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Goldstein-Piekarski</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Gyurak</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Debattista</surname>
                      <given-names>C</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The international Study to Predict Optimized Treatment in Depression (iSPOT-D): outcomes from the acute phase of antidepressant treatment</article-title>
                  <source>J Psychiatr Res</source>
                  <year>2015</year>
                  <volume>61</volume>
                  <fpage>1</fpage>
                  <lpage>12</lpage>
                  <?supplied-pmid 25586212?>
                  <pub-id pub-id-type="pmid">25586212</pub-id>
                </element-citation>
              </ref>
              <ref id="CR5">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ferrari</surname>
                      <given-names>AJ</given-names>
                    </name>
                    <name>
                      <surname>Charlson</surname>
                      <given-names>FJ</given-names>
                    </name>
                    <name>
                      <surname>Norman</surname>
                      <given-names>RE</given-names>
                    </name>
                    <name>
                      <surname>Patten</surname>
                      <given-names>SB</given-names>
                    </name>
                    <name>
                      <surname>Freedman</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Murray</surname>
                      <given-names>CJ</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010</article-title>
                  <source>PLoS Med</source>
                  <year>2013</year>
                  <volume>10</volume>
                  <fpage>e1001547</fpage>
                  <?supplied-pmid 3818162?>
                  <pub-id pub-id-type="pmid">24223526</pub-id>
                </element-citation>
              </ref>
              <ref id="CR6">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Drevets</surname>
                      <given-names>WC</given-names>
                    </name>
                  </person-group>
                  <article-title>Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders</article-title>
                  <source>Curr Opin Neurobiol</source>
                  <year>2001</year>
                  <volume>11</volume>
                  <fpage>240</fpage>
                  <lpage>9</lpage>
                  <?supplied-pmid 11301246?>
                  <pub-id pub-id-type="pmid">11301246</pub-id>
                </element-citation>
              </ref>
              <ref id="CR7">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Smith</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>Fox</surname>
                      <given-names>PT</given-names>
                    </name>
                    <name>
                      <surname>Miller</surname>
                      <given-names>KL</given-names>
                    </name>
                    <name>
                      <surname>Glahn</surname>
                      <given-names>DC</given-names>
                    </name>
                    <name>
                      <surname>Fox</surname>
                      <given-names>PM</given-names>
                    </name>
                    <name>
                      <surname>Mackay</surname>
                      <given-names>CE</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Correspondence of the brain’s functional architecture during activation and rest</article-title>
                  <source>Proc Natl Acad Sci USA</source>
                  <year>2009</year>
                  <volume>106</volume>
                  <fpage>13040</fpage>
                  <lpage>5</lpage>
                  <?supplied-pmid 19620724?>
                  <pub-id pub-id-type="pmid">19620724</pub-id>
                </element-citation>
              </ref>
              <ref id="CR8">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kaiser</surname>
                      <given-names>RH</given-names>
                    </name>
                    <name>
                      <surname>Andrews-Hanna</surname>
                      <given-names>JR</given-names>
                    </name>
                    <name>
                      <surname>Wager</surname>
                      <given-names>TD</given-names>
                    </name>
                    <name>
                      <surname>Pizzagalli</surname>
                      <given-names>DA</given-names>
                    </name>
                  </person-group>
                  <article-title>Large-scale network dysfunction in major depressive disorder: a meta-analysis of resting-state functional connectivity</article-title>
                  <source>JAMA Psychiatry</source>
                  <year>2015</year>
                  <volume>72</volume>
                  <fpage>603</fpage>
                  <lpage>11</lpage>
                  <?supplied-pmid 4456260?>
                  <pub-id pub-id-type="pmid">25785575</pub-id>
                </element-citation>
              </ref>
              <ref id="CR9">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gudayol-Ferre</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Pero-Cebollero</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Gonzalez-Garrido</surname>
                      <given-names>AA</given-names>
                    </name>
                    <name>
                      <surname>Guardia-Olmos</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Changes in brain connectivity related to the treatment of depression measured through fMRI: a systematic review</article-title>
                  <source>Front Hum Neurosci</source>
                  <year>2015</year>
                  <volume>9</volume>
                  <fpage>582</fpage>
                  <?supplied-pmid 26578927?>
                  <pub-id pub-id-type="pmid">26578927</pub-id>
                </element-citation>
              </ref>
              <ref id="CR10">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Brakowski</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Spinelli</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Dorig</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Bosch</surname>
                      <given-names>OG</given-names>
                    </name>
                    <name>
                      <surname>Manoliu</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Holtforth</surname>
                      <given-names>MG</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Resting state brain network function in major depression—depression symptomatology, antidepressant treatment effects, future research</article-title>
                  <source>J Psychiatr Res</source>
                  <year>2017</year>
                  <volume>92</volume>
                  <fpage>147</fpage>
                  <lpage>59</lpage>
                  <?supplied-pmid 28458140?>
                  <pub-id pub-id-type="pmid">28458140</pub-id>
                </element-citation>
              </ref>
              <ref id="CR11">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Posner</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Hellerstein</surname>
                      <given-names>DJ</given-names>
                    </name>
                    <name>
                      <surname>Gat</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Mechling</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Klahr</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>Z</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Antidepressants normalize the default mode network in patients with dysthymia</article-title>
                  <source>JAMA Psychiatry</source>
                  <year>2013</year>
                  <volume>70</volume>
                  <fpage>373</fpage>
                  <lpage>82</lpage>
                  <?supplied-pmid 23389382?>
                  <pub-id pub-id-type="pmid">23389382</pub-id>
                </element-citation>
              </ref>
              <ref id="CR12">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Anand</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Gardner</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Lowe</surname>
                      <given-names>MJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Reciprocal effects of antidepressant treatment on activity and connectivity of the mood regulating circuit: an FMRI study</article-title>
                  <source>J Neuropsychiatry Clin Neurosci</source>
                  <year>2007</year>
                  <volume>19</volume>
                  <fpage>274</fpage>
                  <lpage>82</lpage>
                  <?supplied-pmid 17827412?>
                  <pub-id pub-id-type="pmid">17827412</pub-id>
                </element-citation>
              </ref>
              <ref id="CR13">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Heller</surname>
                      <given-names>AS</given-names>
                    </name>
                    <name>
                      <surname>Johnstone</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Shackman</surname>
                      <given-names>AJ</given-names>
                    </name>
                    <name>
                      <surname>Light</surname>
                      <given-names>SN</given-names>
                    </name>
                    <name>
                      <surname>Peterson</surname>
                      <given-names>MJ</given-names>
                    </name>
                    <name>
                      <surname>Kolden</surname>
                      <given-names>GG</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Reduced capacity to sustain positive emotion in major depression reflects diminished maintenance of fronto-striatal brain activation</article-title>
                  <source>Proc Natl Acad Sci USA</source>
                  <year>2009</year>
                  <volume>106</volume>
                  <fpage>22445</fpage>
                  <lpage>50</lpage>
                  <?supplied-pmid 20080793?>
                  <pub-id pub-id-type="pmid">20080793</pub-id>
                </element-citation>
              </ref>
              <ref id="CR14">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Aizenstein</surname>
                      <given-names>HJ</given-names>
                    </name>
                    <name>
                      <surname>Butters</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Mazurkewicz</surname>
                      <given-names>LM</given-names>
                    </name>
                    <name>
                      <surname>Stenger</surname>
                      <given-names>VA</given-names>
                    </name>
                    <name>
                      <surname>Gianaros</surname>
                      <given-names>PJ</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Altered functioning of the executive control circuit in late-life depression: episodic and persistent phenomena</article-title>
                  <source>Am J Geriatr Psychiatry: Off J Am Assoc Geriatr Psychiatry</source>
                  <year>2009</year>
                  <volume>17</volume>
                  <fpage>30</fpage>
                  <lpage>42</lpage>
                </element-citation>
              </ref>
              <ref id="CR15">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sikora</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Heffernan</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Avery</surname>
                      <given-names>ET</given-names>
                    </name>
                    <name>
                      <surname>Mickey</surname>
                      <given-names>BJ</given-names>
                    </name>
                    <name>
                      <surname>Zubieta</surname>
                      <given-names>JK</given-names>
                    </name>
                    <name>
                      <surname>Pecina</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Salience network functional connectivity predicts placebo effects in major depression</article-title>
                  <source>Biol Psychiatry Cogn Neurosci Neuroimaging</source>
                  <year>2016</year>
                  <volume>1</volume>
                  <fpage>68</fpage>
                  <lpage>76</lpage>
                  <?supplied-pmid 26709390?>
                  <pub-id pub-id-type="pmid">26709390</pub-id>
                </element-citation>
              </ref>
              <ref id="CR16">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Alexopoulos</surname>
                      <given-names>GS</given-names>
                    </name>
                    <name>
                      <surname>Hoptman</surname>
                      <given-names>MJ</given-names>
                    </name>
                    <name>
                      <surname>Kanellopoulos</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Murphy</surname>
                      <given-names>CF</given-names>
                    </name>
                    <name>
                      <surname>Lim</surname>
                      <given-names>KO</given-names>
                    </name>
                    <name>
                      <surname>Gunning</surname>
                      <given-names>FM</given-names>
                    </name>
                  </person-group>
                  <article-title>Functional connectivity in the cognitive control network and the default mode network in late-life depression</article-title>
                  <source>J Affect Disord</source>
                  <year>2012</year>
                  <volume>139</volume>
                  <fpage>56</fpage>
                  <lpage>65</lpage>
                  <?supplied-pmid 3340472?>
                  <pub-id pub-id-type="pmid">22425432</pub-id>
                </element-citation>
              </ref>
              <ref id="CR17">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Li</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Friston</surname>
                      <given-names>KJ</given-names>
                    </name>
                    <name>
                      <surname>Shen</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Zeng</surname>
                      <given-names>LL</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A treatment-resistant default mode subnetwork in major depression</article-title>
                  <source>Biol Psychiatry</source>
                  <year>2013</year>
                  <volume>74</volume>
                  <fpage>48</fpage>
                  <lpage>54</lpage>
                  <?supplied-pmid 23273724?>
                  <pub-id pub-id-type="pmid">23273724</pub-id>
                </element-citation>
              </ref>
              <ref id="CR18">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ma</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Ding</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Guo</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Long</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>F</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Resting-state functional connectivity bias of middle temporal gyrus and caudate with altered gray matter volume in major depression</article-title>
                  <source>PloS One</source>
                  <year>2012</year>
                  <volume>7</volume>
                  <fpage>e45263</fpage>
                  <?supplied-pmid 23028892?>
                  <pub-id pub-id-type="pmid">23028892</pub-id>
                </element-citation>
              </ref>
              <ref id="CR19">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Dunlop</surname>
                      <given-names>BW</given-names>
                    </name>
                    <name>
                      <surname>Rajendra</surname>
                      <given-names>JK</given-names>
                    </name>
                    <name>
                      <surname>Craighead</surname>
                      <given-names>WE</given-names>
                    </name>
                    <name>
                      <surname>Kelley</surname>
                      <given-names>ME</given-names>
                    </name>
                    <name>
                      <surname>McGrath</surname>
                      <given-names>CL</given-names>
                    </name>
                    <name>
                      <surname>Choi</surname>
                      <given-names>KS</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Functional connectivity of the subcallosal cingulate cortex and differential outcomes to treatment with cognitive-behavioral therapy or antidepressant medication for major depressive disorder</article-title>
                  <source>Am J Psychiatry</source>
                  <year>2017</year>
                  <volume>174</volume>
                  <fpage>533</fpage>
                  <lpage>45</lpage>
                  <?supplied-pmid 28335622?>
                  <pub-id pub-id-type="pmid">28335622</pub-id>
                </element-citation>
              </ref>
              <ref id="CR20">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Goldstein-Piekarski</surname>
                      <given-names>AN</given-names>
                    </name>
                    <name>
                      <surname>Staveland</surname>
                      <given-names>BR</given-names>
                    </name>
                    <name>
                      <surname>Ball</surname>
                      <given-names>TM</given-names>
                    </name>
                    <name>
                      <surname>Yesavage</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Korgaonkar</surname>
                      <given-names>MS</given-names>
                    </name>
                    <name>
                      <surname>Williams</surname>
                      <given-names>LM</given-names>
                    </name>
                  </person-group>
                  <article-title>Intrinsic functional connectivity predicts remission on antidepressants: a randomized controlled trial to identify clinically applicable imaging biomarkers</article-title>
                  <source>Transl Psychiatry</source>
                  <year>2018</year>
                  <volume>8</volume>
                  <fpage>57</fpage>
                  <?supplied-pmid 29507282?>
                  <pub-id pub-id-type="pmid">29507282</pub-id>
                </element-citation>
              </ref>
              <ref id="CR21">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Salomons</surname>
                      <given-names>TV</given-names>
                    </name>
                    <name>
                      <surname>Dunlop</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Kennedy</surname>
                      <given-names>SH</given-names>
                    </name>
                    <name>
                      <surname>Flint</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Geraci</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Giacobbe</surname>
                      <given-names>P</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Resting-state cortico-thalamic-striatal connectivity predicts response to dorsomedial prefrontal rTMS in major depressive disorder</article-title>
                  <source>Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol</source>
                  <year>2014</year>
                  <volume>39</volume>
                  <fpage>488</fpage>
                  <lpage>98</lpage>
                </element-citation>
              </ref>
              <ref id="CR22">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fornito</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Zalesky</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Breakspear</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>The connectomics of brain disorders</article-title>
                  <source>Nat Rev Neurosci</source>
                  <year>2015</year>
                  <volume>16</volume>
                  <fpage>159</fpage>
                  <lpage>72</lpage>
                  <pub-id pub-id-type="pmid">25697159</pub-id>
                </element-citation>
              </ref>
              <ref id="CR23">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sporns</surname>
                      <given-names>O</given-names>
                    </name>
                  </person-group>
                  <article-title>The human connectome: a complex network</article-title>
                  <source>Ann N Y Acad Sci</source>
                  <year>2011</year>
                  <volume>1224</volume>
                  <fpage>109</fpage>
                  <lpage>25</lpage>
                  <?supplied-pmid 21251014?>
                  <pub-id pub-id-type="pmid">21251014</pub-id>
                </element-citation>
              </ref>
              <ref id="CR24">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Grieve</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>Korgaonkar</surname>
                      <given-names>MS</given-names>
                    </name>
                    <name>
                      <surname>Etkin</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Harris</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Koslow</surname>
                      <given-names>SH</given-names>
                    </name>
                    <name>
                      <surname>Wisniewski</surname>
                      <given-names>S</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Brain imaging predictors and the international study to predict optimized treatment for depression: study protocol for a randomized controlled trial</article-title>
                  <source>Trials</source>
                  <year>2013</year>
                  <volume>14</volume>
                  <fpage>224</fpage>
                  <?supplied-pmid 23866851?>
                  <pub-id pub-id-type="pmid">23866851</pub-id>
                </element-citation>
              </ref>
              <ref id="CR25">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Williams</surname>
                      <given-names>LM</given-names>
                    </name>
                    <name>
                      <surname>Rush</surname>
                      <given-names>AJ</given-names>
                    </name>
                    <name>
                      <surname>Koslow</surname>
                      <given-names>SH</given-names>
                    </name>
                    <name>
                      <surname>Wisniewski</surname>
                      <given-names>SR</given-names>
                    </name>
                    <name>
                      <surname>Cooper</surname>
                      <given-names>NJ</given-names>
                    </name>
                    <name>
                      <surname>Nemeroff</surname>
                      <given-names>CB</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol</article-title>
                  <source>Trials</source>
                  <year>2011</year>
                  <volume>12</volume>
                  <fpage>4</fpage>
                  <?supplied-pmid 21208417?>
                  <pub-id pub-id-type="pmid">21208417</pub-id>
                </element-citation>
              </ref>
              <ref id="CR26">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sheehan</surname>
                      <given-names>DV</given-names>
                    </name>
                    <name>
                      <surname>Lecrubier</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Sheehan</surname>
                      <given-names>KH</given-names>
                    </name>
                    <name>
                      <surname>Amorim</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Janavs</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Weiller</surname>
                      <given-names>E</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10</article-title>
                  <source>J Clin Psychiatry</source>
                  <year>1998</year>
                  <volume>59</volume>
                  <issue>Suppl 20</issue>
                  <fpage>22</fpage>
                  <lpage>33</lpage>
                  <?supplied-pmid 9881538?>
                  <pub-id pub-id-type="pmid">9881538</pub-id>
                </element-citation>
              </ref>
              <ref id="CR27">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hamilton</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>A rating scale for depression</article-title>
                  <source>J Neurol Neurosurg Psychiatry</source>
                  <year>1960</year>
                  <volume>23</volume>
                  <fpage>56</fpage>
                  <lpage>62</lpage>
                  <?supplied-pmid 14399272?>
                  <pub-id pub-id-type="pmid">14399272</pub-id>
                </element-citation>
              </ref>
              <ref id="CR28">
                <label>28.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lovibond</surname>
                      <given-names>SH</given-names>
                    </name>
                    <name>
                      <surname>Lovibond</surname>
                      <given-names>PF</given-names>
                    </name>
                  </person-group>
                  <source>Manual for the depression anxiety stress scales</source>
                  <year>1995</year>
                  <edition>2nd ed</edition>
                  <publisher-loc>Sydney</publisher-loc>
                  <publisher-name>Psychology Foundation</publisher-name>
                </element-citation>
              </ref>
              <ref id="CR29">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Korgaonkar</surname>
                      <given-names>MS</given-names>
                    </name>
                    <name>
                      <surname>Grieve</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>Etkin</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Koslow</surname>
                      <given-names>SH</given-names>
                    </name>
                    <name>
                      <surname>Williams</surname>
                      <given-names>LM</given-names>
                    </name>
                  </person-group>
                  <article-title>Using standardized fMRI protocols to identify patterns of prefrontal circuit dysregulation that are common and specific to cognitive and emotional tasks in major depressive disorder: first wave results from the iSPOT-D study</article-title>
                  <source>Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol</source>
                  <year>2013</year>
                  <volume>38</volume>
                  <fpage>863</fpage>
                  <lpage>71</lpage>
                </element-citation>
              </ref>
              <ref id="CR30">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Power</surname>
                      <given-names>JD</given-names>
                    </name>
                    <name>
                      <surname>Barnes</surname>
                      <given-names>KA</given-names>
                    </name>
                    <name>
                      <surname>Snyder</surname>
                      <given-names>AZ</given-names>
                    </name>
                    <name>
                      <surname>Schlaggar</surname>
                      <given-names>BL</given-names>
                    </name>
                    <name>
                      <surname>Petersen</surname>
                      <given-names>SE</given-names>
                    </name>
                  </person-group>
                  <article-title>Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion</article-title>
                  <source>NeuroImage</source>
                  <year>2012</year>
                  <volume>59</volume>
                  <fpage>2142</fpage>
                  <lpage>54</lpage>
                  <?supplied-pmid 22019881?>
                  <pub-id pub-id-type="pmid">22019881</pub-id>
                </element-citation>
              </ref>
              <ref id="CR31">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ciric</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Wolf</surname>
                      <given-names>DH</given-names>
                    </name>
                    <name>
                      <surname>Power</surname>
                      <given-names>JD</given-names>
                    </name>
                    <name>
                      <surname>Roalf</surname>
                      <given-names>DR</given-names>
                    </name>
                    <name>
                      <surname>Baum</surname>
                      <given-names>GL</given-names>
                    </name>
                    <name>
                      <surname>Ruparel</surname>
                      <given-names>K</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Benchmarking of participant-level confound regression strategies for the control of motion artifact in studies of functional connectivity</article-title>
                  <source>NeuroImage</source>
                  <year>2017</year>
                  <volume>154</volume>
                  <fpage>174</fpage>
                  <lpage>87</lpage>
                  <?supplied-pmid 28302591?>
                  <pub-id pub-id-type="pmid">28302591</pub-id>
                </element-citation>
              </ref>
              <ref id="CR32">
                <label>32.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Korgaonkar</surname>
                      <given-names>MS</given-names>
                    </name>
                    <name>
                      <surname>Ram</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Williams</surname>
                      <given-names>LM</given-names>
                    </name>
                    <name>
                      <surname>Gatt</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Grieve</surname>
                      <given-names>SM</given-names>
                    </name>
                  </person-group>
                  <article-title>Establishing the resting state default mode network derived from functional magnetic resonance imaging tasks as an endophenotype: a twins study</article-title>
                  <source>Hum brain Mapp</source>
                  <year>2014</year>
                  <volume>35</volume>
                  <fpage>3893</fpage>
                  <lpage>902</lpage>
                  <?supplied-pmid 24453120?>
                  <pub-id pub-id-type="pmid">24453120</pub-id>
                </element-citation>
              </ref>
              <ref id="CR33">
                <label>33.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gordon</surname>
                      <given-names>EM</given-names>
                    </name>
                    <name>
                      <surname>Laumann</surname>
                      <given-names>TO</given-names>
                    </name>
                    <name>
                      <surname>Adeyemo</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Huckins</surname>
                      <given-names>JF</given-names>
                    </name>
                    <name>
                      <surname>Kelley</surname>
                      <given-names>WM</given-names>
                    </name>
                    <name>
                      <surname>Petersen</surname>
                      <given-names>SE</given-names>
                    </name>
                  </person-group>
                  <article-title>Generation and evaluation of a cortical area parcellation from resting-state correlations</article-title>
                  <source>Cereb Cortex</source>
                  <year>2016</year>
                  <volume>26</volume>
                  <fpage>288</fpage>
                  <lpage>303</lpage>
                  <?supplied-pmid 25316338?>
                  <pub-id pub-id-type="pmid">25316338</pub-id>
                </element-citation>
              </ref>
              <ref id="CR34">
                <label>34.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fornito</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Zalesky</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Bullmore</surname>
                      <given-names>ET</given-names>
                    </name>
                  </person-group>
                  <article-title>Network scaling effects in graph analytic studies of human resting-state FMRI data</article-title>
                  <source>Front Syst Neurosci</source>
                  <year>2010</year>
                  <volume>4</volume>
                  <fpage>22</fpage>
                  <?supplied-pmid 20592949?>
                  <pub-id pub-id-type="pmid">20592949</pub-id>
                </element-citation>
              </ref>
              <ref id="CR35">
                <label>35.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zalesky</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Fornito</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Harding</surname>
                      <given-names>IH</given-names>
                    </name>
                    <name>
                      <surname>Cocchi</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Yucel</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Pantelis</surname>
                      <given-names>C</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Whole-brain anatomical networks: does the choice of nodes matter?</article-title>
                  <source>NeuroImage</source>
                  <year>2010</year>
                  <volume>50</volume>
                  <fpage>970</fpage>
                  <lpage>83</lpage>
                  <?supplied-pmid 20035887?>
                  <pub-id pub-id-type="pmid">20035887</pub-id>
                </element-citation>
              </ref>
              <ref id="CR36">
                <label>36.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wang</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Zang</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Tang</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Gong</surname>
                      <given-names>Q</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Parcellation-dependent small-world brain functional networks: a resting-state fMRI study</article-title>
                  <source>Hum Brain Mapp</source>
                  <year>2009</year>
                  <volume>30</volume>
                  <fpage>1511</fpage>
                  <lpage>23</lpage>
                  <?supplied-pmid 18649353?>
                  <pub-id pub-id-type="pmid">18649353</pub-id>
                </element-citation>
              </ref>
              <ref id="CR37">
                <label>37.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tzourio-Mazoyer</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Landeau</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Papathanassiou</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Crivello</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Etard</surname>
                      <given-names>O</given-names>
                    </name>
                    <name>
                      <surname>Delcroix</surname>
                      <given-names>N</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain</article-title>
                  <source>NeuroImage</source>
                  <year>2002</year>
                  <volume>15</volume>
                  <fpage>273</fpage>
                  <lpage>89</lpage>
                  <?supplied-pmid 11771995?>
                  <pub-id pub-id-type="pmid">11771995</pub-id>
                </element-citation>
              </ref>
              <ref id="CR38">
                <label>38.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zalesky</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Fornito</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Bullmore</surname>
                      <given-names>ET</given-names>
                    </name>
                  </person-group>
                  <article-title>Network-based statistic: identifying differences in brain networks</article-title>
                  <source>NeuroImage</source>
                  <year>2010</year>
                  <volume>53</volume>
                  <fpage>1197</fpage>
                  <lpage>207</lpage>
                  <?supplied-pmid 20600983?>
                  <pub-id pub-id-type="pmid">20600983</pub-id>
                </element-citation>
              </ref>
              <ref id="CR39">
                <label>39.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Raichle</surname>
                      <given-names>ME</given-names>
                    </name>
                    <name>
                      <surname>MacLeod</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Snyder</surname>
                      <given-names>AZ</given-names>
                    </name>
                    <name>
                      <surname>Powers</surname>
                      <given-names>WJ</given-names>
                    </name>
                    <name>
                      <surname>Gusnard</surname>
                      <given-names>DA</given-names>
                    </name>
                    <name>
                      <surname>Shulman</surname>
                      <given-names>GL</given-names>
                    </name>
                  </person-group>
                  <article-title>A default mode of brain function</article-title>
                  <source>Proc Natl Acad Sci USA</source>
                  <year>2001</year>
                  <volume>98</volume>
                  <fpage>676</fpage>
                  <lpage>82</lpage>
                  <?supplied-pmid 11209064?>
                  <pub-id pub-id-type="pmid">11209064</pub-id>
                </element-citation>
              </ref>
              <ref id="CR40">
                <label>40.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fox</surname>
                      <given-names>MD</given-names>
                    </name>
                    <name>
                      <surname>Snyder</surname>
                      <given-names>AZ</given-names>
                    </name>
                    <name>
                      <surname>Vincent</surname>
                      <given-names>JL</given-names>
                    </name>
                    <name>
                      <surname>Corbetta</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Van Essen</surname>
                      <given-names>DC</given-names>
                    </name>
                    <name>
                      <surname>Raichle</surname>
                      <given-names>ME</given-names>
                    </name>
                  </person-group>
                  <article-title>The human brain is intrinsically organized into dynamic, anticorrelated functional networks</article-title>
                  <source>Proc Natl Acad Sci USA</source>
                  <year>2005</year>
                  <volume>102</volume>
                  <fpage>9673</fpage>
                  <lpage>8</lpage>
                  <?supplied-pmid 15976020?>
                  <pub-id pub-id-type="pmid">15976020</pub-id>
                </element-citation>
              </ref>
              <ref id="CR41">
                <label>41.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Whitton</surname>
                      <given-names>AE</given-names>
                    </name>
                    <name>
                      <surname>Webb</surname>
                      <given-names>CA</given-names>
                    </name>
                    <name>
                      <surname>Dillon</surname>
                      <given-names>DG</given-names>
                    </name>
                    <name>
                      <surname>Kayser</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Rutherford</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Goer</surname>
                      <given-names>F</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Pretreatment rostral anterior cingulate cortex connectivity with salience network predicts depression recovery: findings from the EMBARC randomized clinical trial</article-title>
                  <source>Biol Psychiatry</source>
                  <year>2019</year>
                  <volume>85</volume>
                  <fpage>872</fpage>
                  <lpage>80</lpage>
                  <?supplied-pmid 30718038?>
                  <pub-id pub-id-type="pmid">30718038</pub-id>
                </element-citation>
              </ref>
              <ref id="CR42">
                <label>42.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Korgaonkar</surname>
                      <given-names>MS</given-names>
                    </name>
                    <name>
                      <surname>Williams</surname>
                      <given-names>LM</given-names>
                    </name>
                    <name>
                      <surname>Song</surname>
                      <given-names>YJ</given-names>
                    </name>
                    <name>
                      <surname>Usherwood</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Grieve</surname>
                      <given-names>SM</given-names>
                    </name>
                  </person-group>
                  <article-title>Diffusion tensor imaging predictors of treatment outcomes in major depressive disorder</article-title>
                  <source>Br J Psychiatry: J Ment Sci</source>
                  <year>2014</year>
                  <volume>205</volume>
                  <fpage>321</fpage>
                  <lpage>8</lpage>
                </element-citation>
              </ref>
              <ref id="CR43">
                <label>43.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Liston</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>AC</given-names>
                    </name>
                    <name>
                      <surname>Zebley</surname>
                      <given-names>BD</given-names>
                    </name>
                    <name>
                      <surname>Drysdale</surname>
                      <given-names>AT</given-names>
                    </name>
                    <name>
                      <surname>Gordon</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Leuchter</surname>
                      <given-names>B</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Default mode network mechanisms of transcranial magnetic stimulation in depression</article-title>
                  <source>Biol Psychiatry</source>
                  <year>2014</year>
                  <volume>76</volume>
                  <fpage>517</fpage>
                  <lpage>26</lpage>
                  <?supplied-pmid 24629537?>
                  <pub-id pub-id-type="pmid">24629537</pub-id>
                </element-citation>
              </ref>
              <ref id="CR44">
                <label>44.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Crowther</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Smoski</surname>
                      <given-names>MJ</given-names>
                    </name>
                    <name>
                      <surname>Minkel</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Moore</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Gibbs</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Petty</surname>
                      <given-names>C</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Resting-state connectivity predictors of response to psychotherapy in major depressive disorder</article-title>
                  <source>Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol</source>
                  <year>2015</year>
                  <volume>40</volume>
                  <fpage>1659</fpage>
                  <lpage>73</lpage>
                </element-citation>
              </ref>
              <ref id="CR45">
                <label>45.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Guo</surname>
                      <given-names>WB</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Xue</surname>
                      <given-names>ZM</given-names>
                    </name>
                    <name>
                      <surname>Xu</surname>
                      <given-names>XJ</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>RR</given-names>
                    </name>
                    <name>
                      <surname>Ma</surname>
                      <given-names>CQ</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Alterations of the amplitude of low-frequency fluctuations in treatment-resistant and treatment-response depression: a resting-state fMRI study</article-title>
                  <source>Prog Neuro-Psychopharmacol Biol Psychiatry</source>
                  <year>2012</year>
                  <volume>37</volume>
                  <fpage>153</fpage>
                  <lpage>60</lpage>
                </element-citation>
              </ref>
              <ref id="CR46">
                <label>46.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Parkes</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Fulcher</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Yucel</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Fornito</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>An evaluation of the efficacy, reliability, and sensitivity of motion correction strategies for resting-state functional MRI</article-title>
                  <source>NeuroImage</source>
                  <year>2018</year>
                  <volume>171</volume>
                  <fpage>415</fpage>
                  <lpage>36</lpage>
                  <?supplied-pmid 29278773?>
                  <pub-id pub-id-type="pmid">29278773</pub-id>
                </element-citation>
              </ref>
              <ref id="CR47">
                <label>47.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Andreescu</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Tudorascu</surname>
                      <given-names>DL</given-names>
                    </name>
                    <name>
                      <surname>Butters</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Tamburo</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Patel</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Price</surname>
                      <given-names>J</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Resting state functional connectivity and treatment response in late-life depression</article-title>
                  <source>Psychiatry Res</source>
                  <year>2013</year>
                  <volume>214</volume>
                  <fpage>313</fpage>
                  <lpage>21</lpage>
                  <?supplied-pmid 24144505?>
                  <pub-id pub-id-type="pmid">24144505</pub-id>
                </element-citation>
              </ref>
              <ref id="CR48">
                <label>48.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wu</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Andreescu</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Butters</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Tamburo</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Reynolds</surname>
                      <given-names>CF</given-names>
                      <suffix>3rd</suffix>
                    </name>
                    <name>
                      <surname>Aizenstein</surname>
                      <given-names>H</given-names>
                    </name>
                  </person-group>
                  <article-title>Default-mode network connectivity and white matter burden in late-life depression</article-title>
                  <source>Psychiatry Res</source>
                  <year>2011</year>
                  <volume>194</volume>
                  <fpage>39</fpage>
                  <lpage>46</lpage>
                  <?supplied-pmid 21824753?>
                  <pub-id pub-id-type="pmid">21824753</pub-id>
                </element-citation>
              </ref>
              <ref id="CR49">
                <label>49.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fales</surname>
                      <given-names>CL</given-names>
                    </name>
                    <name>
                      <surname>Barch</surname>
                      <given-names>DM</given-names>
                    </name>
                    <name>
                      <surname>Rundle</surname>
                      <given-names>MM</given-names>
                    </name>
                    <name>
                      <surname>Mintun</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Snyder</surname>
                      <given-names>AZ</given-names>
                    </name>
                    <name>
                      <surname>Cohen</surname>
                      <given-names>JD</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Altered emotional interference processing in affective and cognitive-control brain circuitry in major depression</article-title>
                  <source>Biol Psychiatry</source>
                  <year>2008</year>
                  <volume>63</volume>
                  <fpage>377</fpage>
                  <lpage>84</lpage>
                  <?supplied-pmid 17719567?>
                  <pub-id pub-id-type="pmid">17719567</pub-id>
                </element-citation>
              </ref>
              <ref id="CR50">
                <label>50.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Williams</surname>
                      <given-names>LM</given-names>
                    </name>
                    <name>
                      <surname>Korgaonkar</surname>
                      <given-names>MS</given-names>
                    </name>
                    <name>
                      <surname>Song</surname>
                      <given-names>YC</given-names>
                    </name>
                    <name>
                      <surname>Paton</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Eagles</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Goldstein-Piekarski</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Amygdala reactivity to emotional faces in the prediction of general and medication-specific responses to antidepressant treatment in the randomized iSPOT-D trial</article-title>
                  <source>Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol</source>
                  <year>2015</year>
                  <volume>40</volume>
                  <fpage>2398</fpage>
                  <lpage>408</lpage>
                </element-citation>
              </ref>
              <ref id="CR51">
                <label>51.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fair</surname>
                      <given-names>DA</given-names>
                    </name>
                    <name>
                      <surname>Schlaggar</surname>
                      <given-names>BL</given-names>
                    </name>
                    <name>
                      <surname>Cohen</surname>
                      <given-names>AL</given-names>
                    </name>
                    <name>
                      <surname>Miezin</surname>
                      <given-names>FM</given-names>
                    </name>
                    <name>
                      <surname>Dosenbach</surname>
                      <given-names>NU</given-names>
                    </name>
                    <name>
                      <surname>Wenger</surname>
                      <given-names>KK</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A method for using blocked and event-related fMRI data to study “resting state” functional connectivity</article-title>
                  <source>NeuroImage</source>
                  <year>2007</year>
                  <volume>35</volume>
                  <fpage>396</fpage>
                  <lpage>405</lpage>
                  <?supplied-pmid 17239622?>
                  <pub-id pub-id-type="pmid">17239622</pub-id>
                </element-citation>
              </ref>
              <ref id="CR52">
                <label>52.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cole</surname>
                      <given-names>MW</given-names>
                    </name>
                    <name>
                      <surname>Bassett</surname>
                      <given-names>DS</given-names>
                    </name>
                    <name>
                      <surname>Power</surname>
                      <given-names>JD</given-names>
                    </name>
                    <name>
                      <surname>Braver</surname>
                      <given-names>TS</given-names>
                    </name>
                    <name>
                      <surname>Petersen</surname>
                      <given-names>SE</given-names>
                    </name>
                  </person-group>
                  <article-title>Intrinsic and task-evoked network architectures of the human brain</article-title>
                  <source>Neuron</source>
                  <year>2014</year>
                  <volume>83</volume>
                  <fpage>238</fpage>
                  <lpage>51</lpage>
                  <?supplied-pmid 24991964?>
                  <pub-id pub-id-type="pmid">24991964</pub-id>
                </element-citation>
              </ref>
              <ref id="CR53">
                <label>53.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fornito</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Harrison</surname>
                      <given-names>BJ</given-names>
                    </name>
                    <name>
                      <surname>Zalesky</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Simons</surname>
                      <given-names>JS</given-names>
                    </name>
                  </person-group>
                  <article-title>Competitive and cooperative dynamics of large-scale brain functional networks supporting recollection</article-title>
                  <source>Proc Natl Acad Sci USA</source>
                  <year>2012</year>
                  <volume>109</volume>
                  <fpage>12788</fpage>
                  <lpage>93</lpage>
                  <?supplied-pmid 22807481?>
                  <pub-id pub-id-type="pmid">22807481</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
